Completed PHASE1 INTERVENTIONAL 1-arm NCT00719407

Neonatal Erythropoietin in Asphyxiated Term Newborns (NEAT)

Neonatal Erythropoietin in Asphyxiated Term Newborns: a Phase I Trial

Sponsor: Santa Clara Valley Health & Hospital System

Conditions Hypoxic-ischemic Encephalopathy

Updated 8 times since 2017 Last updated: Nov 7, 2012 Started: Jan 31, 2010 Primary completion: Sep 30, 2011 Completion: Nov 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Hypoxic-ischemic Encephalopathy, this trial is completed. The trial is conducted by Santa Clara Valley Health & Hospital System and has accumulated 8 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Sep 2020 — Jan 2021 [monthly]

Completed PHASE1
Aug 2019 — Sep 2020 [monthly]

Completed PHASE1

▶ Show 3 earlier versions

Jun 2018 — Aug 2019 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Santa Clara Valley Health & Hospital System
Thrasher Research Fund
UCSF Benioff Children's Hospital Oakland
University of California, San Francisco
University of Washington

Data source: University of California, San Francisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Francisco, United States